$LLY

LLYEli Lilly and Company Common Stock

YouTube 频道最近怎么谈 Eli Lilly and Company(LLY)?

过去 30 天(截至 11-18),9 个 YouTube 频道谈到 Eli Lilly and Company(LLY),共 15 条。最近一条:Schwab Network,2026-11-16。

本窗口内的全部观点与内容

截至 11-18
11-06
《Stock Market Warning: Tech Sells Off as Money Moves HERE!》
$LLY看涨
AI 摘要 · Eli Lilly 估值昂贵,但今日刚进入买入区间,且在全新的加号底部形态上提供了又一次买入机会;由于医疗交易相当活跃,Lilly 现在看起来相当有前景。

这是一只昂贵的股票。它的名字是 Eli Lilly,它今天刚刚进入买入区间,又给了你一次机会。我相信它们总是会再给你一次机会。而且它处在一个漂亮的新鲜基底上。它上涨了,而因为市场不好,它又给了你一次机会。

所以像 Lilly 这样的股票现在看起来相当有前景,因为医疗板块的交易现在相当活跃。

This is an expensive stock. Its name is Eli Lilly and it just arrived at the Buy Zone today and gave you another chance. I believe they always give you another chance. And it's on a nice fresh plus base.

It went up and because the market was bad, it gave you another chance. So stocks like Lilly look quite promising now because the medical trade is quite active now.

11-16
Schwab Network发布 2026-11-16
《Adam Coons On Defense; "No Touch" on NVDA, Avoiding HD and LOW Pre-Earnings》
$LLY看涨
AI 摘要 · Eli Lilly 具有一定防御性;随着减肥药持续上市,接下来是 Retatrutide/GLP-3,它可能成为一款颠覆格局、消灭竞争的产品。说话者称 LLY 与 Google 一样有 10% 至 20% 的上涨空间,两者可因不同原因、在不同情境下跑赢。

像 Google 这样你喜欢的股票。它财报后确实出现了下跌,但整体处于某种上行趋势。还有 Eli Lily。你认为这两只股票都有 10% 到 20% 的上涨潜力吗?

Share like Google that you liked. I mean, it saw that decline after the earnings, but it was in a somewhat upward trend. And Eli Lily. Do you think both of these stocks have a 10 to 20% upside potential?

至于 Eli Lilly,它同样算是一只偏防御性的股票,但他们推出的产品,以及我们看到各种减肥药不断推出。我相信“Retatrotide”是下一个即将投产的产品。有人称它为“GLP-3”。

这款药很可能成为他们在这个领域的颠覆性产品,并可能淘汰其余竞争对手。

As for Eli Lilly, it is once again a somewhat defensive stock , but the products they are putting forward and we see a continuation of the introduction of various obesity drugs.

I believe "Retatrotide" is next in the production line. Some people call it "GLP-3". This drug is likely to be a game-changer for them in this field, and may eliminate the rest of the competition.

11-13
Schwab Network发布 2026-11-13
《PPI Mostly Cool, AI at "Crossroads" Amid NVDA CEO Search》
$LLY看涨
AI 摘要 · Eli Lilly 是一个高溢价成长故事:在表现出色的一年里上涨35%,也是医疗保健板块上涨行情的领跑者之一;它凭借三款领先的 GLP1 产品抓住了医疗保健领域最大的机会,有利的人口结构持续为强劲的研发管线提供顺风,因此其高溢价估值是合理的。

Eli Lilly 是你名单上的名字之一。我猜这是对 GLP1 领域的押注,但请给我们讲讲你的投资逻辑。正是如此。Eli Lilly 今年表现很好,上涨了35%,确实是这轮医疗保健行情中的领跑者之一。

正如你提到的,他们凭借三款领先的 GLP1 产品,抓住了当前医疗保健领域最大的机会。

Eli Lilly is one of those names on your list. I'm betting this is a bet on the GLP1 space, but walk us through your thesis here. Exactly. You know, Eli Lilly's had a great year up 35% and really one of the leaders of that healthcare run.

As you mentioned, they've been able to capitalize on, you know, really the the biggest opportunity right now in healthcare with their three leading GLP1 products.

11-12
Schwab Network发布 2026-11-12
《The Big 3: JNJ, LLY, AAPL》
$LLY看涨
AI 摘要 · Eli Lilly 技术面强劲,说话者预计将出现一段有节制的上行:较快的移动平均线有利于多头,但该股尚未令人信服地突破 14.50 的上限,且 RSI 显示看跌背离。他更倾向于用期权结构在捕捉上行空间的同时限制下行风险,目标 1560–1600,理想涨幅 8–10%;该股估值偏高、期权操作难度大,而医疗保健板块到 2027 年应保持相对强势。

你的下一个选择也在医疗保健板块。我们有 Eli Lilly。我是说,也许 Eli Lilly 的图表在技术面上更清晰。那么,你对 Lilly 的前景怎么看?观点类似。从技术角度看,动量肯定是在的。

但同样,我从根本上认为,随着我们进入2027年,医疗保健板块将继续展现出相对强度。这是一只昂贵的股票。由于股票的规模和期权的成本,很难在它上面构建期权头寸。不过,我仍然相信有机会,这就是为什么我今天看交易示例时,重点是在期权上构建一笔交易。

因此,在某种程度上,我们识别下行风险,同时具备捕捉价格上涨的能力。

Your next choice is also in the healthcare sector. We have Eli Lilly. I mean, perhaps Eli Lilly's chart is more technically clear. So , what is your outlook for Lilly? A similar view.

The momentum is definitely there from a technical standpoint. But again, I fundamentally believe that the healthcare sector will continue to demonstrate relative strength as we enter 2027.

It is an expensive stock. It is difficult to structure options positions on it due to the size of the stock and the cost of the options as well. However, I still believe there are opportunities, and that's why when I looked at the trading example today, the focus was on structuring a deal around options.

Therefore, to some extent, we identify downside risks with the ability to capture upward price movements.

11-10
Parkev Tatevosian, CFA发布 2026-11-10
《My Forever Portfolio: 4 Spectacular Stocks You Can Buy Now and Never Sell》
$LLY看涨
AI 摘要 · 礼来是一只可以永久买入并持有的推荐标的,因为其数十年来接连不断的成功——不只是减肥药——使当前的成功并非昙花一现;股价为1,366美元,而他给出的估值为1,662美元,他持有该股并希望继续加仓。

你在这里看到的是我的估值,以及我为我要提到的第一只股票所做的现金流折现模型。这只股票你现在就可以买入并永久持有,它就是Eli Lilly。

What you see here is my valuation, and my discounted cash flow model for the first stock I'm going to mention that you can buy now and hold forever, which is Eli Lilly.

Eli Lilly是一家制药公司,在研发治疗药物方面拥有数十年经验,这些药物带来了数十亿美元的销售额和利润。目前,该公司正受益于其在减肥治疗领域最近取得的成功,但这家公司有着一个成功接着一个成功的历史。

Eli Lilly is a pharmaceutical company with decades of experience in researching and developing treatments that generate billions of dollars in sales and profits. Currently, the company is benefiting from its recent success in weight loss treatments, but the company has a history of one success after another.

11-07
Everything Money发布 2026-11-07
《Why The Nasdaq is Really Crashing in 2026 (Sell Now or Buy the Dip?)》
$LLY看跌
AI 摘要 · 暂无中文摘要,仅英文原句可核对。

礼来(Eli Lilly)这家以热门减肥疗法闻名的制药公司,股价创下近1450美元/股的历史新高。其销售额在上个季度大幅跃升了39%。

Eli Lilly, the pharmaceutical company responsible for popular weight-loss treatments, hit a record high of nearly $1,450 per share. Its sales jumped by a massive 39% in the last quarter.

11-03
T3 Live发布 2026-11-03
《Scott Redler’s #630club - LIVE Premarket Stock Market Update》
$LLY看涨
AI 摘要 · LLY 表现非常出色,技术面走势良好——它向上突破并守住了 8 日均线;说话者表示要看 1387 的低点能否守住。

太多东西都坏掉了。是的,非科技股看起来还行。所以,如果你想持有 Eli Liy,Eli Liy 的表现一直非常出色。如果你想靠吃药减肥,我不评判你,你也可以那么做。我打算去我儿子那儿,泡我的冰桶,出一身汗。

但全世界有7%的人在吃药减肥。好吧。总之,这只股票的技术面一直表现不错。给了你一波行情,守住了8日线。我有个朋友,他每个孩子的大学学费都是他付的,因为他给小女儿取名叫 Lily。

Lily 走出了一波巨大的行情。它跌了11,1397。这里的低点是多少?1387。所以,看看这个位置能不能守住。

So many freaking broken stuff. Yes, non tech looks okay. So, if you want to be in Eli Liy, Eli Liy has been doing absolutely fantastic. You know, if you want to take a pill to lose weight, I'm not judging you.

You could do that, too. I'm going to go on my son and my ice barrel and I'm going to sweat. But 7% of the world is taking pills to lose weight. Okay. Anyway, um stock technically has been acting well.

Gave you a move, held the eight day. Um go, you know, I have a friend who who's paying for every one of his kids college because he named his little daughter Lily. And uh Lily has had a tremendous run.

It's down 11 1397. Um what's this low here? 1387. So, um, see if that holds.

他说在等
1387低点是否守住
守住1387
近期1387低点处的价格走势
支持建设性的技术面观点
11-02
Verified Investing发布 2026-11-02
《Oil Drops Sharply Triggering Market Surge, Silver Bounces As AI Tech Trade Is Back On, Top Trades!》
$LLY看跌
AI 摘要 · Eli Lilly 是说话者目前最看好的做空标的之一。在 AI 交易崩盘之际它刚创新高,周五的小十字星可能是反转信号,下跌或许已经开始。他关注价格跌至 1290 附近以回补枢轴位缺口,这是经典的回调形态。

各位,目前我最喜欢的做空标的之一就是这只——Eli Lilly。还是Eli Lilly,如果你看月线图,你和我都会发誓这是一只AI股票,但它实际上是一只制药股。近期人工智能领域出现了重大行情。

看看这里的上涨走势:当AI交易在崩盘时,Eli Lilly却涨到了新的历史高点。周五录得一根小“十字星”K线,这可能是反转信号。再说一次,有可能开始下跌。我会关注它是否跌到1290附近。

回补这个缺口也正好对应这个枢轴点的高点,对吧?所以再说一次,先回补那里的缺口,然后是那个枢轴点。Eli Lilly的股票形态看起来很可能出现一次经典的回落机会。

One of my favorite short-selling deals right now, guys, is this one. Eli Lilly. Eli Lilly again, if you go to your monthly chart, you would swear and I would swear that this is an AI stock, but it is actually a pharmaceutical stock.

A major movement recently in artificial intelligence. Look at this upward movement here: while the AI trade was collapsing, Eli Lilly rose to new record highs. A small "Doji" candlestick was recorded on Friday, which could be a reversal signal.

Once again, there is a possibility of a decline beginning. I'll be watching for a drop to around 1290 here. Bridging this gap also represents the peak of this pivot point here, isn't it?

So again, bridge the gap there and then that pivot point there. A classic pullback opportunity seems likely in Eli Lilly's stock setup .

已显示 8 / 本页 15 条
看这只股票的全部记录